Nilotinib
- Level
- Commodity
- Parent
- 51111800
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51111862This classification denotes a tyrosine kinase inhibitor with the molecular formula C28H22F3N7O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F41401512X. European Medicines Agency schedules nilotinib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25225. The term NILOTINIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, no. 3, 2006, list 56). Most nations schedule nilotinib under HS 29335990 and SITC 51576. As of Q4 2014, NILOTINIB remains the US FDA Preferred Term for this commodity. Nilotinib bears US NLM identifiers UMLS ID C1721377 and NCI Concept Code C48375. SMILES: CL.FC(F)(F)C1CC(N2CC(NC2)C)CC(NC(=O)C2CC(NC3NC(C4CCCNC4)CCN3)C(CC2)C)C1.O.
Same parent
Under 51111800 · 55Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.